ABVC BioPharma, Inc.
ABVC · NASDAQ
Bulios Fair Price
$0.88
19.3% downside
Trenutna cena
$1.09
Po podatkih Bulios Fair Price je delnica ABVC trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
ABVC BioPharma, Inc. is a biotechnology company focused on researching and developing new therapeutic approaches in the fields of oncology and immunotherapy. The company aims to discover drugs that can target specific immune mechanisms and potentially improve the treatment of various types of cancer. ABVC BioPharma strives to bring innovations to cancer treatment and support patients' immune systems in fighting the disease. Their research is directed towards developing drugs that can intervene in complex biological processes associated with cancer. Investors interested in the biotechnology sector and new therapeutic strategies in oncology might see potential in ABVC BioPharma, Inc. (ABVC) shares for innovation and growth in this field.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Uttam Yashwant Patil
Employees
18
Headquarters
Fremont
Prihajajoči dogodki
Earnings
Upcoming earnings report